Bioptimus is an AI company that offers a foundation model for biology to fuel breakthrough discoveries and accelerate.
Bioptimus has raised $41.0M in total funding. The most recent round was Series A. The last funding was announced in January 2025.
Bioptimus's investors include Bpifrance, Headline, Cathay Innovation, Hummingbird Ventures, Hitachi Ventures.
Bioptimus is headquartered in Paris, France.
Bioptimus is an AI company that offers a foundation model for biology to fuel breakthrough discoveries and accelerate.
Bioptimus is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bioptimus — Funding & Investors." VCBacked, January 14, 2025, https://www.vcbacked.co/company/bioptimus. Accessed October 18, 2026.
VCBacked. (2025). Bioptimus — Funding & Investors. Retrieved October 18, 2026, from https://www.vcbacked.co/company/bioptimus
{{cite web |title=Bioptimus — Funding & Investors |url=https://www.vcbacked.co/company/bioptimus |website=VCBacked |access-date=October 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated